[go: up one dir, main page]

WO2016009401A3 - Préparation du phosphate de tédizolid - Google Patents

Préparation du phosphate de tédizolid Download PDF

Info

Publication number
WO2016009401A3
WO2016009401A3 PCT/IB2015/055428 IB2015055428W WO2016009401A3 WO 2016009401 A3 WO2016009401 A3 WO 2016009401A3 IB 2015055428 W IB2015055428 W IB 2015055428W WO 2016009401 A3 WO2016009401 A3 WO 2016009401A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
tedizolid phosphate
tedizolid
phosphate
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2015/055428
Other languages
English (en)
Other versions
WO2016009401A2 (fr
Inventor
Abhishek Sud
Pramod CHAUDHARI
Rakeshwar Bandichhor
Vilas Hareshwar Dahanukar
Venkata Annapurna Sasi Kala CHEEMALAPATI
Dasameswara Rao KAVITAPU
Jaydeepkumar Dahyabhai Lilakar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of WO2016009401A2 publication Critical patent/WO2016009401A2/fr
Publication of WO2016009401A3 publication Critical patent/WO2016009401A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des procédés de préparation du phosphate de tédizolid.
PCT/IB2015/055428 2014-07-18 2015-07-17 Préparation du phosphate de tédizolid Ceased WO2016009401A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN3551/CHE/2014 2014-07-18
IN3551CH2014 2014-07-18
IN2166/CHE/2015 2015-04-28
IN2166CH2015 2015-04-28

Publications (2)

Publication Number Publication Date
WO2016009401A2 WO2016009401A2 (fr) 2016-01-21
WO2016009401A3 true WO2016009401A3 (fr) 2016-03-17

Family

ID=55079133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/055428 Ceased WO2016009401A2 (fr) 2014-07-18 2015-07-17 Préparation du phosphate de tédizolid

Country Status (1)

Country Link
WO (1) WO2016009401A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106855548B (zh) * 2016-12-21 2019-10-25 天津红日药业股份有限公司 一种磷酸泰地唑胺有关物质分析方法
CN107121503B (zh) * 2017-03-14 2020-04-28 南京优科制药有限公司 一种磷酸特地唑胺及其有关物质的分析方法
CN107382995A (zh) * 2017-09-01 2017-11-24 杭州新博思生物医药有限公司 一锅法合成泰地唑胺
CN110669072B (zh) * 2019-09-11 2022-04-19 天方药业有限公司 磷酸特地唑胺的精制方法
WO2021258013A1 (fr) 2020-06-18 2021-12-23 Akagera Medicines, Inc. Composés du type oxazolidinone, compositions de liposome comprenant des composés du type oxazolidinone et méthodes d'utilisation associées
CN111995616A (zh) * 2020-09-22 2020-11-27 宜宾市南溪区红光制药有限公司 一种磷酸特地唑胺杂质及其制备方法和用途
CN112961186A (zh) * 2021-02-04 2021-06-15 海南通用康力制药有限公司 一种磷酸特地唑胺的纯化方法
CN115792047B (zh) * 2023-02-10 2023-05-19 四川美域高生物医药科技有限公司 一种磷酸特地唑胺中间体有关物质的检测方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058886A1 (fr) * 2003-12-18 2005-06-30 Dong-A Pharm.Co.,Ltd. Nouveaux derives d'oxazolidinone
WO2010042887A2 (fr) * 2008-10-10 2010-04-15 Trius Therapeutics Procédés pour préparer des oxazolidinones et compositions contenant celles-ci
US20100227839A1 (en) * 2009-02-03 2010-09-09 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058886A1 (fr) * 2003-12-18 2005-06-30 Dong-A Pharm.Co.,Ltd. Nouveaux derives d'oxazolidinone
WO2010042887A2 (fr) * 2008-10-10 2010-04-15 Trius Therapeutics Procédés pour préparer des oxazolidinones et compositions contenant celles-ci
US20100227839A1 (en) * 2009-02-03 2010-09-09 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate

Also Published As

Publication number Publication date
WO2016009401A2 (fr) 2016-01-21

Similar Documents

Publication Publication Date Title
WO2016149710A8 (fr) Anticorps neutralisant le vih-1 et leurs utilisations
WO2016011222A3 (fr) Polynucléotides circulaires
WO2016079696A3 (fr) Revêtements polymères conducteurs pour substrats tridimensionnels
WO2016061389A3 (fr) Anticorps anti-alpha-synucléine et leurs méthodes d'utilisation
EP3160921A4 (fr) Procédé de préparation d'extraits humiques à partir de sources fossiles
WO2016009401A3 (fr) Préparation du phosphate de tédizolid
EP3166931A4 (fr) Procédé perfectionné pour la préparation d'enzalutamide
WO2015191945A3 (fr) Formes solides de sofosbuvir
EP3166927A4 (fr) Procédé pour la préparation d'acides 4-alcoxy-3-hydroxypicoliniques
EP3280408A4 (fr) Procédé de préparation de dicycloplatine
EP3694499A4 (fr) Nouveau procédé de préparation de lifitegrast
WO2016138538A3 (fr) Utilisation thérapeutique d'anticorps de liaison à l'intégrine
WO2016079110A3 (fr) Utilisation d'enzymes pour le nettoyage
WO2015092810A3 (fr) Forme amorphe d'idélalisib
EP3405456A4 (fr) Procédé de préparation d'acides alcoxy-3-acétoxypicoliniques
WO2016108206A3 (fr) Procédés de préparation d'idélalisib et de ses intermédiaires
EP3222624A4 (fr) Composé d'acide imidique ayant un anion divalent, et son procédé de fabrication
EP3166928A4 (fr) Procédé de préparation d'acides 3--hydroxypicoliniques
EP3532055A4 (fr) Compositions et procédés pour la production de composés
EP3233814A4 (fr) Nouveau procédé de préparation de ranolazine
EP3134465A4 (fr) Compositions de revêtement améliorées et leurs procédés de préparation
EP3016935A4 (fr) Procédé pour la préparation d'intermédiaire de dolutégravir
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
EP3706740A4 (fr) Processus de production de l'acalabrutinib
EP3422855A4 (fr) Procédé de préparation d'acides 4-alcoxy-3-hydroxypicoliniques

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15822071

Country of ref document: EP

Kind code of ref document: A2